Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
WYNN enters the final stretch before its November 4 earnings report with short sellers adding positions at the fastest monthly pace in recent history, while every analyst who has touched the stock this quarter has trimmed their price target, even as the consensus remains firmly bullish.
Short interest has climbed steadily and now reaches 9.1% of the free float, up 14% over the past month and 5.5% on the week alone. The build has been consistent rather than episodic: looking back through September, the short position has added roughly a million shares since mid-August. That is a meaningful accumulation for a stock already carrying a double-digit short load. The ORTEX short score has tracked the move higher, reaching 59.4 this week from 56.5 a fortnight ago, its highest reading in the recent window. Importantly, the borrow market is not sending a squeeze warning. Availability is running at 408%, meaning there are roughly four shares available to borrow for every one currently shorted. Cost to borrow is just 0.57%, near the low end of the past six months. The message from the lending market is that bears are building with little friction and no sign of a crowded borrow.
Options positioning has also shifted. The put/call ratio is 0.63, nudging against its 52-week high of 0.65 and running above its 20-day average of 0.57 by nearly a full standard deviation. That is not an extreme, but it points in the same direction as the short interest trend: hedging demand is rising into earnings, not falling. The stock itself is down 2.1% on the week and 16.3% over the past month, closing at $76.62. Peer pressure is not the sole explanation. LVS fell 5.2% on the week and MLCO dropped 7%, so Macau-exposed names broadly are under pressure, but WYNN's year-to-date decline has been steeper than most.
The Street remains constructive in rating but is visibly losing conviction on the price. Macquarie cut its target this week from $143 to $132 while holding its Outperform. UBS trimmed from $145 to $138 in September. Wolfe Research initiated at Outperform with a $128 target. The consensus mean now sits around $131.90, implying roughly 72% upside from the current price. That gap is striking. Bulls point to sub-9x forward EBITDA, a 6% year-on-year EBITDAR gain in the most recent quarter, mass drop in Macau up 19%, and long-dated development options including the 2027 UAE integrated resort and a new 432-suite tower in 2029. Bears counter that the business is structurally tied to high-end discretionary spending and carries real Macau regulatory risk, with expensive construction programmes underway in mature markets. The EV/EBITDA sits near 7.4x, drifting lower over the past month, and the PE is around 15.2x, both compressing with the stock. The EPS surprise factor score ranks in the 86th percentile, suggesting the company has generally delivered above estimates when it has reported, even if forward momentum scores are soft.
On the ownership side, Capital Research and Management is the largest institutional holder at roughly 9.97% of shares, and added around 968,000 shares in the most recently reported period. BlackRock sits at 6.2% and also added modestly. Tilman Fertitta holds around 8.7% through his personal stake, with Fertitta Entertainment adding a further 4.1%. No 13D activist is on the register, and all major 13G holders are passive. Gillian Wynn filed a 13G/A in August showing her stake down from 9.17% to 5.65%, a reduction worth noting as the most recent change in the founding family's visible footprint. Insider activity in the formal sense has been minimal: the only recent Form 4 activity was a small tax-withholding transaction by the General Counsel in September, not a market signal.
Wikipedia attention for WYNN is running above its own 90-day average, with a z-score of 1.2 as of late September, suggesting retail interest in the name has ticked up even as the stock has sold off. The prior two earnings prints produced modest positive day-one moves of roughly 1% and 2.8%, with the five-day drift extending further after the August report. The next print on November 4 is therefore the near-term focus: whether the current wave of short-building and target-cutting reflects genuine fundamental deterioration or is positioning that gets unwound on the release is what the market will be watching.
See the live data behind this article on ORTEX.
Open WYNN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
